Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 4,523,924 | +4,523,924 | $0 | $112.37M | 62.43% | +$112.37M |
| Centessa Pharmaceuticals plc | 3,931,818 | 3,931,818 | 0 | $31.30M | $44.43M | 24.68% | +$13.13M |
| Dyne Therapeutics, Inc.(DYN) | 2,074,787 | 407,499 | -1,667,288 | $27.59M | $11.57M | 6.43% | -$16.03M |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | $5.77M | $8.04M | 4.47% | +$2.27M |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | $3.46M | $3.59M | 2.00% | +$138.3K |
| Kinnate Biopharma, Inc. | 2,207,772 | 0 | -2,207,772 | $5.23M | $0 | — | -$5.23M |
| LianMedical(LIANY) | 2,282,084 | 0 | -2,282,084 | $10.20M | $0 | — | -$10.20M |
| Ikena Oncology, Inc. | 225,192 | 0 | -225,192 | $443.6K | $0 | — | -$443.6K |